Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Operating Leases (2019 - 2025)

Pulmonx (LUNG) has disclosed Operating Leases for 7 consecutive years, with $18.3 million as the latest value for Q3 2025.

  • Quarterly Operating Leases rose 2.17% to $18.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $18.3 million through Sep 2025, up 2.17% year-over-year, with the annual reading at $18.5 million for FY2024, 1574.05% up from the prior year.
  • Operating Leases for Q3 2025 was $18.3 million at Pulmonx, down from $19.7 million in the prior quarter.
  • The five-year high for Operating Leases was $19.8 million in Q1 2025, with the low at $650000.0 in Q1 2024.
  • Average Operating Leases over 5 years is $9.7 million, with a median of $7.8 million recorded in 2022.
  • The sharpest move saw Operating Leases tumbled 80.27% in 2023, then soared 2938.92% in 2025.
  • Over 5 years, Operating Leases stood at $6.8 million in 2021, then plummeted by 43.76% to $3.8 million in 2022, then crashed by 71.27% to $1.1 million in 2023, then skyrocketed by 1574.05% to $18.5 million in 2024, then decreased by 1.17% to $18.3 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $18.3 million, $19.7 million, and $19.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.